TY - JOUR
T1 - Cardiac rehabilitation outcome following percutaneous coronary intervention compared to cardiac surgery
AU - Izawa, Kazuhiro P.
AU - Watanabe, Satoshi
AU - Oka, Koichiro
AU - Hiraki, Koji
AU - Morio, Yuji
AU - Kasahara, Yusuke
AU - Osada, Naohiko
AU - Omiya, Kazuto
AU - Makuuchi, Haruo
PY - 2011/5/1
Y1 - 2011/5/1
N2 - To examine differences in objective and subjective outcomes in outpatients undergoing percutaneous coronary intervention (PCI) performed for acute myocardial infarction versus cardiac surgery (CS) following a phase II cardiac rehabilitation (CR). Longitudinal observational study of 437 consecutive cardiac outpatients after 8 weeks of phase II CR. Patients were divided into the PCI group (n = 281) and CS group (n = 156). Handgrip and knee extensor muscle strength, peak oxygen uptake (VO2), upper- and lower-body self-efficacy for physical activity (SEPA), and physical component summary (PCS) and mental component summary (MCS) scores as assessed by Short Form-36 were measured at 1 and 3 months after PCI or CS. All outcomes increased significantly between months 1 and 3 in both groups. However, increases were greater in the CS versus PCI group in handgrip strength (+12.3 % vs. +8.1%, P < 0.01), knee extensor muscle strength (+19.3% vs. +17.5%, P = 0.008), peak VO2 (+20.9% vs. +16.9%, P < 0.01), upper-body SEPA (+27.7% vs. +9.2%, P = 0.001), and PCS score (+6.5% vs. +4.1%, P = 0.001). Although this relatively short-term phase II CR increased all outcomes for both groups, outcomes showed the recovery process was different between the PCI and CS groups, slightly favoring CS patients. Furthermore, patents in the field of CR are presented.
AB - To examine differences in objective and subjective outcomes in outpatients undergoing percutaneous coronary intervention (PCI) performed for acute myocardial infarction versus cardiac surgery (CS) following a phase II cardiac rehabilitation (CR). Longitudinal observational study of 437 consecutive cardiac outpatients after 8 weeks of phase II CR. Patients were divided into the PCI group (n = 281) and CS group (n = 156). Handgrip and knee extensor muscle strength, peak oxygen uptake (VO2), upper- and lower-body self-efficacy for physical activity (SEPA), and physical component summary (PCS) and mental component summary (MCS) scores as assessed by Short Form-36 were measured at 1 and 3 months after PCI or CS. All outcomes increased significantly between months 1 and 3 in both groups. However, increases were greater in the CS versus PCI group in handgrip strength (+12.3 % vs. +8.1%, P < 0.01), knee extensor muscle strength (+19.3% vs. +17.5%, P = 0.008), peak VO2 (+20.9% vs. +16.9%, P < 0.01), upper-body SEPA (+27.7% vs. +9.2%, P = 0.001), and PCS score (+6.5% vs. +4.1%, P = 0.001). Although this relatively short-term phase II CR increased all outcomes for both groups, outcomes showed the recovery process was different between the PCI and CS groups, slightly favoring CS patients. Furthermore, patents in the field of CR are presented.
KW - Cardiac rehabilitation
KW - Cardiac surgery
KW - Health-related quality of life
KW - Muscle strength
KW - Percutaneous coronary intervention
KW - Self-efficacy for physical activity
UR - http://www.scopus.com/inward/record.url?scp=79959394995&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=79959394995&partnerID=8YFLogxK
U2 - 10.2174/157489011795933846
DO - 10.2174/157489011795933846
M3 - Article
C2 - 21513490
AN - SCOPUS:79959394995
VL - 6
SP - 133
EP - 139
JO - Recent Patents on Cardiovascular Drug Discovery
JF - Recent Patents on Cardiovascular Drug Discovery
SN - 1574-8901
IS - 2
ER -